China Resources Double-Crane Pharmaceutical Co.,Ltd.

XSSC:600062 Stock Report

Market Cap: CN¥22.3b

China Resources Double-Crane PharmaceuticalLtd Future Growth

Future criteria checks 1/6

China Resources Double-Crane PharmaceuticalLtd is forecast to grow earnings and revenue by 17.3% and 9.7% per annum respectively. EPS is expected to grow by 17% per annum. Return on equity is forecast to be 13.2% in 3 years.

Key information

17.3%

Earnings growth rate

17.0%

EPS growth rate

Pharmaceuticals earnings growth19.4%
Revenue growth rate9.7%
Future return on equity13.2%
Analyst coverage

Low

Last updated30 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:600062 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202613,2522,159N/A2,6002
12/31/202513,0551,933N/A2,3213
12/31/202412,0171,763N/A1,8733
9/30/202410,3221,3481,0821,840N/A
6/30/202410,3081,3951,2071,801N/A
3/31/202410,2851,3741,2011,812N/A
12/31/202310,2221,3331,0261,631N/A
9/30/202310,9161,5841,2961,811N/A
6/30/202310,5581,4281,0281,514N/A
3/31/20239,8801,2238881,357N/A
12/31/20229,6251,1808901,416N/A
9/30/20229,3941,0256111,258N/A
6/30/20229,3921,0787201,337N/A
3/31/20229,2229816181,198N/A
12/31/20219,1129368491,341N/A
9/30/20219,0061,0219041,269N/A
6/30/20218,9871,0469641,328N/A
3/31/20218,7301,0169561,318N/A
12/31/20208,5041,0051,0121,360N/A
9/30/20208,3481,0109561,238N/A
6/30/20208,6639711,0681,323N/A
3/31/20208,9301,0011,1231,347N/A
12/31/20199,3811,0551,1981,440N/A
9/30/20199,3221,0431,1921,430N/A
6/30/20199,0031,0241,1951,428N/A
3/31/20198,7209971,2891,541N/A
12/31/20188,2259691,2401,469N/A
9/30/20187,9759621,3861,589N/A
6/30/20187,434905N/A1,406N/A
3/31/20187,032908N/A1,271N/A
12/31/20176,422843N/A1,187N/A
9/30/20176,103838N/A1,071N/A
6/30/20175,725801N/A1,107N/A
3/31/20175,584767N/A911N/A
12/31/20165,495714N/A771N/A
9/30/20165,490705N/A828N/A
6/30/20165,414684N/A775N/A
3/31/20165,274645N/A813N/A
12/31/20155,138661N/A701N/A
9/30/20155,733865N/A1,025N/A
6/30/20155,562832N/A1,016N/A
3/31/20155,413785N/A876N/A
12/31/20145,153737N/A929N/A
9/30/20144,276776N/A674N/A
6/30/20145,184845N/A539N/A
3/31/20146,010859N/A637N/A
12/31/20136,835871N/A546N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600062's forecast earnings growth (17.3% per year) is above the savings rate (2.8%).

Earnings vs Market: 600062's earnings (17.3% per year) are forecast to grow slower than the CN market (26.1% per year).

High Growth Earnings: 600062's earnings are forecast to grow, but not significantly.

Revenue vs Market: 600062's revenue (9.7% per year) is forecast to grow slower than the CN market (14% per year).

High Growth Revenue: 600062's revenue (9.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600062's Return on Equity is forecast to be low in 3 years time (13.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y